74 related articles for article (PubMed ID: 2250912)
21. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.
Yu J; Miehlke S; Ebert MP; Hoffmann J; Breidert M; Alpen B; Starzynska T; Stolte Prof M; Malfertheiner P; Bayerdörffer E
Cancer; 2000 Apr; 88(8):1801-6. PubMed ID: 10760755
[TBL] [Abstract][Full Text] [Related]
22. Activation of a mcf.2 oncogene by deletion of amino-terminal coding sequences.
Noguchi T; Galland F; Batoz M; Mattei MG; Birnbaum D
Oncogene; 1988 Dec; 3(6):709-15. PubMed ID: 2577874
[TBL] [Abstract][Full Text] [Related]
23. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours.
Fischer J; Palmedo G; von Knobloch R; Bugert P; Prayer-Galetti T; Pagano F; Kovacs G
Oncogene; 1998 Aug; 17(6):733-9. PubMed ID: 9715275
[TBL] [Abstract][Full Text] [Related]
24. Independently activated dbl oncogenes exhibit similar yet distinct structural alterations.
Eva A; Vecchio G; Diamond M; Tronick SR; Ron D; Cooper GM; Aaronson SA
Oncogene; 1987; 1(4):355-60. PubMed ID: 3330779
[TBL] [Abstract][Full Text] [Related]
25. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M
Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
27. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
EXS; 1993; 65():311-28. PubMed ID: 8380739
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the mouse met proto-oncogene.
Chan AM; King HW; Deakin EA; Tempest PR; Hilkens J; Kroezen V; Edwards DR; Wills AJ; Brookes P; Cooper CS
Oncogene; 1988 Jun; 2(6):593-9. PubMed ID: 2838789
[TBL] [Abstract][Full Text] [Related]
29. The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia.
von Lindern M; van Agthoven T; Hagemeijer A; Adriaansen H; Grosveld G
Oncogene; 1989 Jan; 4(1):75-9. PubMed ID: 2644612
[TBL] [Abstract][Full Text] [Related]
30. The Met/hepatocyte growth factor receptor (HGFR) gene is overexpressed in some cases of human leukemia and lymphoma.
Jücker M; Günther A; Gradl G; Fonatsch C; Krueger G; Diehl V; Tesch H
Leuk Res; 1994 Jan; 18(1):7-16. PubMed ID: 8289471
[TBL] [Abstract][Full Text] [Related]
31. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.
Rodrigues GA; Park M
Mol Cell Biol; 1993 Nov; 13(11):6711-22. PubMed ID: 8413267
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the transgenome of MET transfectant cell lines reveals that MET activation is accompanied by an interstitial insertion.
Scambler PJ; Wainwright B; Ramsay M; Farrall M; Bates G; Ho MF; Cooper C
Hum Genet; 1990 Feb; 84(3):274-8. PubMed ID: 2303248
[TBL] [Abstract][Full Text] [Related]
33. The oncogene ETS1 is distant from the chromosome 11 breakpoint in leukaemic cells with the t(11;19)(q23;p13).
Kennedy MA; Morris CM; Fitzgerald PH
Leuk Res; 1989; 13(6):459-63. PubMed ID: 2671514
[TBL] [Abstract][Full Text] [Related]
34. Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.
Mäkelä TP; Kere J; Winqvist R; Alitalo K
Mol Cell Biol; 1991 Aug; 11(8):4015-21. PubMed ID: 1649386
[TBL] [Abstract][Full Text] [Related]
35. Molecular mapping of the oncogene MYB and rearrangements in malignant melanoma.
Meese E; Meltzer PS; Witkowski CM; Trent JM
Genes Chromosomes Cancer; 1989 Sep; 1(1):88-94. PubMed ID: 2487149
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a rearrangement in the c-MYB promoter in the acute lymphoblastic leukemia cell line CCRF-CEM.
Jacobs SM; Gorse KM; Kennedy SJ; Westin EH
Cancer Genet Cytogenet; 1994 Jul; 75(1):31-9. PubMed ID: 8039161
[TBL] [Abstract][Full Text] [Related]
37. Cosmid mapping and locus linkage within the human chromosomal region 22q13.1.
Blin N; Müllenbach R; Suijkerbuijk R; Herzog R; Meese E
Cancer Genet Cytogenet; 1993 Oct; 70(2):108-11. PubMed ID: 8242588
[TBL] [Abstract][Full Text] [Related]
38. The human met oncogene is related to the tyrosine kinase oncogenes.
Dean M; Park M; Le Beau MM; Robins TS; Diaz MO; Rowley JD; Blair DG; Vande Woude GF
Nature; 1985 Nov 28-Dec 4; 318(6044):385-8. PubMed ID: 4069211
[TBL] [Abstract][Full Text] [Related]
39. B-raf oncogene: activation by rearrangements and assignment to human chromosome 7.
Kamiyama T; Aoki N; Yuasa Y
Jpn J Cancer Res; 1993 Mar; 84(3):250-6. PubMed ID: 8098025
[TBL] [Abstract][Full Text] [Related]
40. The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2.
Martinerie C; Cannizzaro LA; Croce CM; Huebner K; Katzav S; Barbacid M
Hum Genet; 1990 Nov; 86(1):65-8. PubMed ID: 2253939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
